Medical Devices
Thermal Ablation Devices Market

Thermal Ablation Devices Market Size, Share, Growth, and Regional Forecast, 2026 - 2033

Thermal Ablation Devices Market by Product (Systems, Probes), Technology (Radiofrequency Ablation, Hydrothermal Ablation, Microwave Ablation, Laser Ablation, Ultrasound Ablation), End-user, and Regional Analysis from 2026 - 2033

ID: PMRREP11419

December 2025

208 Pages

Author : Abhijeet Surwase

Healthcare

Key Industry Highlights

Leading Region: North America dominates the global market with 37.1%, driven by high procedural adoption, strong reimbursement systems, and widespread availability of advanced image-guided ablation technologies.
Fastest-Growing Region: Asia Pacific market is expected to grow rapidly with a CAGR of 10.9% in the forecast period, fueled by expanding cancer burden, improving healthcare infrastructure, and rising preference for minimally invasive procedures across developing economies.
Leading Product: Probes lead with 67.4% share, supported by their essential role in all thermal ablation modalities, consistent replacement demand, and increasing use in CT- and ultrasound-guided interventions.
Leading Technology: Radiofrequency Ablation to remain dominant with 39.2%, driven by its clinical familiarity, cost-effectiveness, broad oncology applications, and strong evidence base supporting safety and procedural efficacy.
Leading End-user: Hospitals lead with 72.8% share, due to higher patient inflow, advanced imaging facilities, skilled specialists, and greater adoption of multidisciplinary treatment pathways requiring ablation technologies.
Rising preference for same-day ablation procedures that reduce hospitalization costs and improve patient throughput in busy clinical settings.
Thermal ablation adoption rises with private hospital investments in advanced interventional suites, enabling broader access to high-precision ablation technologies in emerging markets.

Key Insights	Details
Global Thermal Ablation Devices Market Size (2026E)	US$ 5.2 Billion
Market Value Forecast (2033F)	US$ 9.3 Billion
Projected Growth (CAGR 2026 to 2033)	8.7%
Historical Market Growth (CAGR 2020 to 2025)	7.4%

thermal-ablation-devices-market-2026–2033

Get Your CustomizationGet Your Customization

Market Dynamics

Driver - Rising Minimally Invasive Oncology Adoption Accelerates Market Expansion

The global thermal ablation devices market is gaining strong momentum as ultrasound-guided modalities—such as microwave ablation, radiofrequency ablation, and laser ablation—become widely recognized as effective, minimally invasive options for treating cancers, including cervical and thyroid tumors. Their adoption is rising particularly in low- and middle-income countries (LMICs), where cervical cancer remains a major cause of mortality. In 2022 alone, more than 350,000 cervical cancer deaths were reported, with over 90% occurring in LMICs.

To support the World Health Organization’s (WHO) 2030 elimination strategy, countries are increasingly replacing cryotherapy—often expensive and operationally restrictive—with thermal ablation (TA), a portable, safe, and cost-efficient alternative endorsed by WHO. Large-scale initiatives funded by Unitaid and implemented with CHAI, national governments, and the SUCCESS group have accelerated this transition. By mid-2024, over 6,000 thermal ablation (TA) devices had been deployed across 28 countries, and more than 11,000 healthcare providers trained. Multiple deployment models—tiered, universal, and demand-driven—help integrate TA into local screening programs while reducing treatment costs by nearly 75%, to about $4.10 per patient.

With Ministries of Health in ten Unitaid–CHAI countries incorporating TA into national guidelines and extending access to primary and secondary care, thermal ablation is becoming central to expanding affordable cancer treatment globally.

Restraints - Device Performance Variability and Procedural Limitations Continue to Restrict Broader Adoption

Despite significant progress, reliability and durability concerns continue to limit the full-scale adoption of thermal ablation devices in global health systems. Data collected between 2020 and 2022 from nearly 3,000 deployed Liger HTU-110 and Wisap C3 units across public facilities in nine countries reported a device-incident rate of under 1%, indicating generally strong performance.

However, the nature of the incidents highlights persistent technical challenges. Approximately 34% of recorded issues were linked to battery or charger failures—critical components for portable devices operating in remote or resource-limited environments. Another 34% of incidents involved probe-related defects, including cracking or inadequate heating, which directly affects treatment consistency.

Additionally, around 17% of malfunctions resulted from devices failing to heat properly due to causes outside the probe or battery systems. While no adverse clinical events were reported, such recurring operational challenges can undermine provider confidence, increase maintenance demands, and create interruptions in service delivery. For many LMICs where supply-chain delays and limited biomedical engineering capacity already constrain healthcare delivery, even low incident rates can slow adoption. These technical reliability issues remain an important restraint on broader thermal ablation scale-up.

Opportunity - Advances in Portable, Image-Guided, and AI-Enhanced Ablation Systems Unlock New Growth Opportunities Worldwide

The global thermal ablation devices market is positioned for major expansion as innovations, clinical evidence, and cross-border collaborations reshape the field. A key milestone came in June 2024, when a publication reported that a portable, low-cost, battery-powered thermal ablator—co-developed by the International Agency for Research on Cancer (IARC) and engineering partners—matched the safety and efficacy of standard-of-care cervical precancer treatments in the largest randomized trial conducted to date. This strengthens the case for broader global adoption.

Additionally, momentum is growing in oncology communities worldwide. At the ISMIO 2025 Annual Conference held in Suzhou in June 2025, experts from China, Russia, Turkey, Kazakhstan, Pakistan, and other countries shared advances in cryo-thermal and microwave ablation techniques for solid tumors, highlighting rising academic and clinical interest.

Technology partnerships are also opening new avenues; in October 2025, Techsomed Ltd. began a pilot collaboration with Medtronic, integrating its BioTraceIO360 AI-powered imaging software with the Emprint microwave ablation system. This aims to improve real-time visualization, predictive margin control, and intraprocedural planning—addressing persistent challenges such as inadequate margin assessment and fragmented imaging workflows. Together, these developments create strong opportunities for innovation, adoption, and market growth in thermal ablation technologies.

Category-wise Analysis

By Product Insights

Probes are expected to capture a 67.4% share of the global thermal ablation devices market by 2026, supported by their versatility across multiple ablation modalities, including microwave, radiofrequency, and laser systems. Their compatibility with image-guided platforms and ability to deliver controlled energy to targeted tissues make them essential in oncology, hepatology, cardiology, and gynecology. Continuous advancements in probe design—such as enhanced heat resistance, flexible shaft architecture, and improved temperature feedback—further strengthen adoption. As minimally invasive procedures expand, clinicians increasingly prefer high-precision probes for safe, predictable, and reproducible treatment outcomes across diverse clinical settings.

By Technology Insights

Radiofrequency ablation is projected to hold nearly 39.2% of the global thermal ablation devices market in 2026, driven by its long-established clinical validation and broad therapeutic use across liver, kidney, lung, and bone tumors. Its extensive safety profile, predictable thermal behavior, and cost-effectiveness make it a preferred modality in both developed and emerging regions. RFA also benefits from widespread availability, streamlined workflows, and compatibility with standard imaging systems. Ongoing refinements in electrode design and energy-delivery algorithms continue to improve precision, further reinforcing its position as a cornerstone technology in interventional oncology and pain management.

By End-user Insights

Hospitals are projected to account for nearly 72.8% of the global market in 2026, supported by their advanced imaging infrastructure, availability of trained interventional specialists, and ability to perform complex ablation procedures safely. High patient inflows, multidisciplinary oncology teams, and better reimbursement alignment further drive adoption. Hospitals also serve as primary hubs for microwave, radiofrequency, cryoablation, and laser procedures requiring real-time monitoring and postoperative care. With expanding interventional oncology suites and rising preference for minimally invasive treatments, hospitals continue to perform the majority of ablation interventions globally, sustaining their dominant market position.

thermal-ablation-devices-market-outlook-by-product-2026–2033

Request Free sampleRequest Free sample

Regional Insights

North America Thermal Ablation Devices Market Trends

North America is projected to remain the largest regional contributor, capturing nearly 37.1% of the global thermal ablation devices market by 2026, supported by rapid regulatory progress and expanding clinical adoption. Francis Medical, Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Vanquish® Water Vapor Ablation System for prostate tissue ablation. The approval was based on promising 12-month follow-up results from the first 110 patients enrolled in the ongoing VAPOR 2 clinical study, a prospective, multicenter, single-arm trial designed to treat 235 individuals with intermediate-risk, localized prostate cancer across 26 U.S. sites.

The Vanquish System, a transurethral, ultrasound- and electromagnetically guided water-vapor device, enables thermal ablation in an outpatient setting, reflecting North America’s strong inclination toward minimally invasive, patient-friendly therapies. With initial procedures completed in February 2025 and longer-term data being collected to support future premarket approval (PMA) submissions, the region continues to advance next-generation ablation technologies. These developments reinforce North America’s leadership in commercialization, clinical evidence generation, and accelerated innovation pipelines.

Europe Thermal Ablation Devices Market Trends

Europe, expected to account for 29.6% of the global thermal ablation devices market by 2026, is benefitting from continuous technological upgrades and widening access to minimally invasive oncology solutions.

A defining milestone occurred in July 2025 when Varian, a Siemens Healthineers company, launched IntelliBlate, its next-generation microwave ablation platform, across Europe following CE-mark approval. Designed to enhance precision, control, and predictability in tumor treatment, IntelliBlate strengthens Europe’s focus on integrated and clinician-friendly ablation ecosystems. Its introduction supports the region’s shift toward advanced interventional oncology techniques that reduce hospital stays, improve procedural accuracy, and expand therapeutic options for soft-tissue tumors.

By offering a more intuitive and comprehensive platform, IntelliBlate accelerates the adoption of image-guided microwave ablation across European centers. This aligns with the region’s strong infrastructure for medical innovation, robust regulatory frameworks, and emphasis on expanding minimally invasive care. As providers increasingly seek technologies that blend automation, accuracy, and workflow integration, Europe continues to drive momentum for high-performance thermal ablation devices.

Asia Pacific Thermal Ablation Devices Market Trends

The Asia Pacific region is emerging as the fastest-growing market for thermal ablation devices, projected to expand at a CAGR of 10.9% during the forecast period. Much of this momentum comes from rapid regulatory approvals, rising cancer incidence, and strong domestic innovation.

A key driver was the March 2024 announcement by Baird Medical Devices, Inc., which received a new Class III certification from the National Medical Products Administration (NMPA) in China for its next-generation Ceramic Thyroid Ablation Needle. This device, developed for the management of thyroid nodules, incorporates rare-earth ceramic materials that provide exceptional heat resistance, chemical stability, and electrical insulation.

These properties enable highly controlled thermal delivery, minimize procedural complications, and ensure uniform energy distribution—an improvement over conventional MWA designs where edge-heating is a concern. With a 30% increase in mechanical strength, the needle enhances flexibility and reduces breakage risk during delicate procedures. As regional manufacturers continue introducing advanced, cost-effective solutions tailored to high-volume clinical needs, Asia Pacific strengthens its position as a dynamic growth engine for thermal ablation innovation and adoption.

thermal-ablation-devices-market-outlook-by-region-2026–2033

Competitive Landscape

The global thermal ablation device market is highly competitive, driven by rapid innovation in energy delivery, imaging integration, and minimally invasive platforms. Manufacturers compete aggressively on device precision, safety, procedural versatility, and cost-effectiveness. Market players strive to differentiate through cutting-edge technologies, regulatory approvals, and expanding use across oncology, cardiology, and ambulatory care settings.

Key Industry Developments:

In October 2025, Monteris Medical and Symphony Robotics today revealed a strategic alliance to launch an AI-driven micro-robotic platform for MRI-guided brain laser ablation. The system features a flexible, engine-less micro-robotic arm that navigates through a 5 mm entry to reach complex or irregular lesions and enables non-linear laser probe trajectories for enhanced precision during treatment of brain tumours, epilepsy foci, and challenging anatomical targets.
In September 2024, The Quad Cancer Moonshot was launched by the United States, Australia, India, and Japan to strengthen cancer care across the Indo-Pacific - expanding prevention, detection, treatment and care infrastructure. The initiative promotes wider access to screening and treatment options (including thermal ablation) for cervical and other cancers. With coordinated research funding, bulk procurement of diagnostics, improved imaging and radiotherapy access, and support for vaccination and early detection programmes, Quad aims to reduce cancer burden and improve equitable care across underserved regions

Companies Covered in Thermal Ablation Devices Market

Medtronic
Boston Scientific Corp.
Smith+Nephew
AngioDynamics
Abbott
Johnson & Johnson
Olympus
STARmed America Inc.
Thermedical, Inc.
ECO Medical
Kardium
Terumo
Vantage Medtech
Francis Medical, Inc.
Seimens Healthineers AG
Baird Medical Devices, Inc
Arthrex, Inc.
Cambridge Interventional

Frequently Asked Questions

The global thermal ablation devices market is projected to be valued at US$ 5.2 Billion in 2026.

Rising cancer prevalence, growing adoption of minimally invasive procedures, and expanding use of image-guided interventions drive market growth.

The global market is poised to witness a CAGR of 8.7% between 2026 and 2033.

Advances in navigation/robotic guidance, expansion into outpatient settings, and increasing adoption in emerging markets present major growth opportunities.

Major players in the thermal ablation devices market are Medtronic, Boston Scientific Corp., Smith+Nephew, AngioDynamics, Abbott, Johnson & Johnson, and others.

Report Attribute	Details
Historical Data/Actuals	2020 - 2025
Forecast Period	2026 - 2033
Market Analysis	Value: US$ Mn, Volume (Units)
Geographical Coverage	North America Europe East Asia South Asia & Oceania Latin America Middle East and Africa
Segmental Coverage	Product Technology End-user Region
Competitive Analysis	Medtronic Boston Scientific Corp. Smith+Nephew AngioDynamics Abbott Johnson & Johnson Olympus STARmed America Inc. Thermedical, Inc. ECO Medical Kardium Terumo Vantage Medtech Francis Medical, Inc. Seimens Healthineers AG Baird Medical Devices, Inc Arthrex, Inc. Cambridge Interventional
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis Future Opportunities and Revenue Pockets Market Analysis Tools

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Key Insights

Details

Global Thermal Ablation Devices Market Size (2026E)

US$ 5.2 Billion

Market Value Forecast (2033F)

US$ 9.3 Billion

Projected Growth (CAGR 2026 to 2033)

8.7%

Historical Market Growth (CAGR 2020 to 2025)

7.4%

Report Attribute	Details
Historical Data/Actuals	2020 - 2025
Forecast Period	2026 - 2033
Market Analysis	Value: US$ Mn, Volume (Units)
Geographical Coverage	North America Europe East Asia South Asia & Oceania Latin America Middle East and Africa
Segmental Coverage	Product Technology End-user Region
Competitive Analysis	Medtronic Boston Scientific Corp. Smith+Nephew AngioDynamics Abbott Johnson & Johnson Olympus STARmed America Inc. Thermedical, Inc. ECO Medical Kardium Terumo Vantage Medtech Francis Medical, Inc. Seimens Healthineers AG Baird Medical Devices, Inc Arthrex, Inc. Cambridge Interventional
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis Future Opportunities and Revenue Pockets Market Analysis Tools

Executive Summary
1. Global Thermal Ablation Devices Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 - 2033, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Product Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. Key Deals and Mergers
5. PESTLE Analysis
6. Porter’s Five Force Analysis
Price Analysis, 2025A
1. Key Highlights
2. Key Factors Impacting Product Prices
3. Pricing Analysis, By Product
4. Regional Prices and Product Preferences
Global Thermal Ablation Devices Market Outlook:
1. Key Highlights
  1. Market Volume (Units) Projections
  2. Market Size (US$ Mn) and Y-o-Y Growth
  3. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2020-2025
  2. Market Size (US$ Mn) Analysis and Forecast, 2026-2033
3. Global Thermal Ablation Devices Market Outlook: Product
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2020-2025
  3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2026-2033
    1. Systems
    2. Probes
  4. Market Attractiveness Analysis: Product
4. Global Thermal Ablation Devices Market Outlook: Technology
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Technology, 2020-2025
  3. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2026-2033
    1. Radiofrequency Ablation
    2. Hydrothermal Ablation
    3. Microwave Ablation
    4. Laser Ablation
    5. Ultrasound Ablation
  4. Market Attractiveness Analysis: Technology
5. Global Thermal Ablation Devices Market Outlook: End User
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By End User, 2020-2025
  3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
    1. Hospitals
    2. Clinics
    3. Ambulatory Surgical Centers
    4. Others
  4. Market Attractiveness Analysis: End User
Global Thermal Ablation Devices Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Region, 2020-2025
3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026-2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Thermal Ablation Devices Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Product
  3. By Technology
  4. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. U.S.
  2. Canada
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2026-2033
  1. Systems
  2. Probes
5. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2026-2033
  1. Radiofrequency Ablation
  2. Hydrothermal Ablation
  3. Microwave Ablation
  4. Laser Ablation
  5. Ultrasound Ablation
6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
  1. Hospitals
  2. Clinics
  3. Ambulatory Surgical Centers
  4. Others
7. Market Attractiveness Analysis
Europe Thermal Ablation Devices Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Product
  3. By Technology
  4. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2026-2033
  1. Systems
  2. Probes
5. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2026-2033
  1. Radiofrequency Ablation
  2. Hydrothermal Ablation
  3. Microwave Ablation
  4. Laser Ablation
  5. Ultrasound Ablation
6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
  1. Hospitals
  2. Clinics
  3. Ambulatory Surgical Centers
  4. Others
7. Market Attractiveness Analysis
East Asia Thermal Ablation Devices Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Product
  3. By Technology
  4. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2026-2033
  1. Systems
  2. Probes
5. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2026-2033
  1. Radiofrequency Ablation
  2. Hydrothermal Ablation
  3. Microwave Ablation
  4. Laser Ablation
  5. Ultrasound Ablation
6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
  1. Hospitals
  2. Clinics
  3. Ambulatory Surgical Centers
  4. Others
7. Market Attractiveness Analysis
South Asia & Oceania Thermal Ablation Devices Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Product
  3. By Technology
  4. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2026-2033
  1. Systems
  2. Probes
5. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2026-2033
  1. Radiofrequency Ablation
  2. Hydrothermal Ablation
  3. Microwave Ablation
  4. Laser Ablation
  5. Ultrasound Ablation
6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
  1. Hospitals
  2. Clinics
  3. Ambulatory Surgical Centers
  4. Others
7. Market Attractiveness Analysis
Latin America Thermal Ablation Devices Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Product
  3. By Technology
  4. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2026-2033
  1. Systems
  2. Probes
5. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2026-2033
  1. Radiofrequency Ablation
  2. Hydrothermal Ablation
  3. Microwave Ablation
  4. Laser Ablation
  5. Ultrasound Ablation
6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
  1. Hospitals
  2. Clinics
  3. Ambulatory Surgical Centers
  4. Others
7. Market Attractiveness Analysis
Middle East & Africa Thermal Ablation Devices Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Product
  3. By Technology
  4. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2026-2033
  1. Systems
  2. Probes
5. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2026-2033
  1. Radiofrequency Ablation
  2. Hydrothermal Ablation
  3. Microwave Ablation
  4. Laser Ablation
  5. Ultrasound Ablation
6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2026-2033
  1. Hospitals
  2. Clinics
  3. Ambulatory Surgical Centers
  4. Others
7. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Medtronic
    1. Overview
    2. Segments and Products
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Boston Scientific Corp.
  3. Smith+Nephew
  4. AngioDynamics
  5. Abbott
  6. Johnson & Johnson
  7. Olympus
  8. STARmed America Inc.
  9. Thermedical, Inc.
  10. ECO Medical
  11. Kardium
  12. Terumo
  13. Vantage Medtech
  14. Francis Medical, Inc.
  15. Seimens Healthineers AG
  16. Baird Medical Devices, Inc
  17. Arthrex, Inc.
  18. Cambridge Interventional
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Thermal Ablation Devices Market Size, Share, Growth, and Regional Forecast, 2026 - 2033

Thermal Ablation Devices Market by Product (Systems, Probes), Technology (Radiofrequency Ablation, Hydrothermal Ablation, Microwave Ablation, Laser Ablation, Ultrasound Ablation), End-user, and Regional Analysis from 2026 - 2033